| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/21/2007 | EP1753431A1 Pharmaceutical compositions comprising zd6474 |
| 02/21/2007 | EP1753404A1 Microspheres comprising protein and showing injectability at high concentrations of said agent |
| 02/21/2007 | EP1753397A2 Galantamine salts, method of producing it and nasal composition thereof |
| 02/21/2007 | EP1753293A2 Anti-microbial activity of biologically stabilized silver nano particles |
| 02/21/2007 | EP1608362B1 Stabilized pharmaceutical preparation comprising an amorphous active substance |
| 02/21/2007 | EP1523325A4 Methods and compositions for treating polycystic ovary syndrome |
| 02/21/2007 | EP1463513B1 Stabilized brivudine topical formulations |
| 02/21/2007 | EP1389466B1 A dispersion on the basis of beta-glucan containing superfine particles, a corresponding process of manufacturing and the use of said dispersion |
| 02/21/2007 | EP1328546B1 Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator |
| 02/21/2007 | EP1328254B1 Lipid formulations for target delivery |
| 02/21/2007 | EP1303635B1 Method for the selective survival or selective growth of a target cell by the use of a conjugate, its use in the therapeutics and/or diagnostics |
| 02/21/2007 | EP1276459B8 Cosmetic or dermatological cream composition, the preparation and the use thereof |
| 02/21/2007 | EP1222932B1 Compositions for electroporation |
| 02/21/2007 | EP1189602B1 Morphine sulphate microgranules, method for preparing same and compositions containing same |
| 02/21/2007 | EP1140071B1 Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors |
| 02/21/2007 | EP1057483B1 Composition comprising theanine |
| 02/21/2007 | EP1034007B1 METHOD FOR THE PRODUCTION OF A ONE DOSE SYRINGE, COMPRISING A FREEZE-DRIED PROTEIN COMPOSITION, FOR ADMINISTERING A VOLUME LESS THAN 0.5 ml |
| 02/21/2007 | EP0981381B1 Polyhydroxyalkanoates for in vivo applications |
| 02/21/2007 | EP0975333B1 Sustained-release alginate gels |
| 02/21/2007 | EP0942996B8 Thrombolytic agents with antithrombotic activity |
| 02/21/2007 | EP0797456B1 Anticancer drug with a cytostatic and a contrasting agent |
| 02/21/2007 | CN1918293A Substituted non-coding nucleic acid molecule for therapeutic or prophylaxis immunological stimulus for human and higher animal |
| 02/21/2007 | CN1918111A Formulation auxiliary agents |
| 02/21/2007 | CN1917905A Process for the production of conjugates from polysaccharides and polynucleotides |
| 02/21/2007 | CN1917904A Use of organo-silicon compounds for constraining connective damaged tissues |
| 02/21/2007 | CN1917891A Medicament on the basis of honey, preparation and use thereof |
| 02/21/2007 | CN1917861A Stabilised compositions of factor vii polypeptides |
| 02/21/2007 | CN1917859A Drug-containing nanoparticle, process for producing the same and parenterally administered preparation from the nanoparticle |
| 02/21/2007 | CN1917782A A drink containing ultrafine powder of ginseng and the method thereof |
| 02/21/2007 | CN1916050A Injectable temperature sensitive hydrogel of poly (lactide ¿C glycolide ¿C p-dioxane ketone) - polyethyleneglycol block copolymer |
| 02/21/2007 | CN1916001A Method of producing addition products of compounds containing sih groups onto reactants having one double bond on aqueous media |
| 02/21/2007 | CN1915968A Neutral-cationic lipid for nucleic acid and drug delivery |
| 02/21/2007 | CN1915966A Derivative of new type menthol, preparation method and application |
| 02/21/2007 | CN1915431A Method for preparing carrier of hollow microsphere for medication in use for treating gastrointestinal tract |
| 02/21/2007 | CN1915430A Nano composite material of quaternary ammonium salt of chitosan/rectorite, and preparation method |
| 02/21/2007 | CN1915228A Soft capsule of indapamide |
| 02/21/2007 | CN1915227A Method for preparing drop pills |
| 02/21/2007 | CN1915221A Liposome of alkaloid in vinca, and preparation method |
| 02/21/2007 | CN1915218A Sodium sulfonate injection of tanshinone óÄA, and preparation method |
| 02/21/2007 | CN1915217A Self-emulsifying agent of compound artemether |
| 02/21/2007 | CN1915215A Oral cavity disintegration preparation |
| 02/21/2007 | CN1301285C Hydrous gel and production process and use of the hydrous gel |
| 02/21/2007 | CN1301134C Novel immune effect compound |
| 02/21/2007 | CN1301104C Sustained release preparations and process for producing the same |
| 02/20/2007 | US7179891 A proteinaceous part having TNF activity and a high molecular polyethylene part bound artificially to the N-terminus of the proteinaceous part, with higher stability; antitumor agents |
| 02/20/2007 | US7179795 Nucleic acids encoding chimeric proteins comprising BMP-2 and a proteinase inhibitor |
| 02/20/2007 | US7179794 Antibiotics; bactericides |
| 02/20/2007 | US7179771 Composition |
| 02/20/2007 | US7179660 Useful in diagnostic and therapeutic methods |
| 02/20/2007 | US7179495 Hyperforin as cytostatic agent and hyperforin ointment or cream as application form |
| 02/20/2007 | US7179490 Sustained release ionic conjugate |
| 02/20/2007 | US7179489 Mixing micronised formoterol its salt or solvate with a pre-micronised carrier/diluent at low energy, agglomerating and spheronisation or adding a coarse carrier/diluent; treating respiratory system disorders |
| 02/20/2007 | US7179484 Protein-stabilized liposomal formulations of pharmaceutical agents |
| 02/20/2007 | US7179483 Compositions and methods for transdermal oxybutynin therapy |
| 02/20/2007 | US7179476 Medical composition for external use for dermatosis |
| 02/20/2007 | US7179475 Anhydrous topical skin preparations |
| 02/20/2007 | US7179445 Cobalamin conjugates useful as imaging and therapeutic agents |
| 02/20/2007 | US7179407 Zero order release and temperature-controlled microcapsules and process for the preparation thereof |
| 02/20/2007 | CA2375225C Mutual salt of amlodipine and atorvastatin |
| 02/20/2007 | CA2284058C Diffusional implantable delivery system |
| 02/20/2007 | CA2283929C Method for treating headache pain with topical local anesthetic compositions |
| 02/20/2007 | CA2151438C Thermostable trehalose-releasing enzyme, and its preparation and uses |
| 02/17/2007 | CA2556287A1 Methods of treatment using vascular occlusion in combination with one or more therapies |
| 02/15/2007 | WO2007019331A2 Conjugates of a g-csf moiety and a polymer |
| 02/15/2007 | WO2007019128A1 Stabilizers for veterinary vaccines |
| 02/15/2007 | WO2007018622A2 Vaginal treatment composition |
| 02/15/2007 | WO2007018583A2 Human growth hormone conjugated with biocompatible polymer |
| 02/15/2007 | WO2007018544A2 Tri-block copolymers for nanosphere-based drug delivery |
| 02/15/2007 | WO2007018431A2 Triazole-containing releasable linkers and conjugates comprising the same |
| 02/15/2007 | WO2007018275A1 Design of delivery medium based on rolling model |
| 02/15/2007 | WO2007018273A1 Composition for delivering diagnostic agent containing sugar-modified liposome |
| 02/15/2007 | WO2007018272A1 Sugar-modified liposome and composition for drug delivery containing the liposome |
| 02/15/2007 | WO2007018210A1 Adhesive patch less irritative to skin |
| 02/15/2007 | WO2007018192A1 Orally disintegratable tablet |
| 02/15/2007 | WO2007018190A1 Bitterness-reducing agent |
| 02/15/2007 | WO2007018147A1 Pharmaceutical titanium dioxide composite material of which pharmacological effect can be eliminated by light irradiation |
| 02/15/2007 | WO2007018057A1 Tablet rapidly disintegrating in the oral cavity and method of producing the same |
| 02/15/2007 | WO2007017539A1 Novel solid carotenoid formulations and production method thereof |
| 02/15/2007 | WO2007016777A1 Targeted protein kinase c inhibitors and uses thereof |
| 02/15/2007 | WO2007016766A1 Transdermal drug delivery formulation |
| 02/15/2007 | WO2007016764A1 Composition and method for prevention and treatment of type i diabetes |
| 02/15/2007 | WO2007016763A1 Peptides targeted to protein kinase c isoforms and uses thereof |
| 02/15/2007 | WO2007016757A1 Stabilized extended release pharmeceutical compositions comprising an hmg-coa reductase inhibitor |
| 02/15/2007 | WO2006128937A3 Nanoparticles comprising chitosan and cyclodextrin |
| 02/15/2007 | WO2006107903A3 Polymeric micelles for drug delivery |
| 02/15/2007 | WO2006106521A8 Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules |
| 02/15/2007 | WO2006103638A3 Topical pharmaceutical compositions of terbinafine and processes for their preparation |
| 02/15/2007 | WO2006071693A3 Injectable non-aqueous suspension |
| 02/15/2007 | WO2005110487A3 Camptothecin derivatives conjugated in position 20 with integrin antagonists |
| 02/15/2007 | WO2005105154A8 Polymer conjugate releasable under mild thiolytic conditions |
| 02/15/2007 | US20070037967 conjugated by bridging molecules to proteins or polypeptides, reporter groups or cytotoxic agents; cancer |
| 02/15/2007 | US20070037891 Methods and compositions for the delivery of biologically active agents |
| 02/15/2007 | US20070037884 Novel succinate salt of O-desmethyl-venlafaxine |
| 02/15/2007 | US20070037825 Enhancing the effect of radioimmunotherapy in the treatment of tumors |
| 02/15/2007 | US20070037777 Lipid-containing compositions and methods of using them |
| 02/15/2007 | US20070037765 gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 02/15/2007 | US20070037750 Exendin agonist composed of a peptide in which at least one amino acid residue is acylated with a dicarboxylic acid; the amino acid residues are an internal lysine residue, an N-terminal amino acid residue, and/or a C-terminal amino acid residue; treatment of glucagonoma |
| 02/15/2007 | US20070037739 Compounds useful in coating stents to prevent and treat stenosis and restenosis |
| 02/15/2007 | US20070036868 oily vitamin derivatives, gelling agent such as agarose, carrageenan and carrageenan-carob mixture, and protein, except gelatine; preparing solution or suspension, forming oil in water emulsion, adding to vegetable oil to for oil-water-oil emulsion, solidifying, cooling, drying |
| 02/15/2007 | US20070036860 Treatment of allergic conditions |